Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Masimo Beats Q3 Earnings Estimates, Cuts Revenue Outlook
Yahoo/Zacks.com
Thursday, October 30, 2014 - 5:32pm
tags:
Masimo, earnings, devices
Avanir Inroads in Alzheimer’s Justify Offers: Real M&A
Bloomberg
Thursday, October 30, 2014 - 12:22pm
tags:
M&A, Avanir, Alzheimer's disease, Lundbeck, Eli Lilly, Mallinckrodt, Shire
Bayer Raises Forecast on New Drugs, Consumer-Health Unit
Bloomberg
Thursday, October 30, 2014 - 12:21pm
tags:
Bayer, consumer health, earnings
Did Novartis Make a Ham-Handed Move to Promote an Antibiotic for Pigs?
WSJ Pharmalot
Thursday, October 30, 2014 - 12:18pm
tags:
Novartis, animal health, antibiotics, antibiotic resistance
Chris Viehbacher leaving Sanofi without a U.S.-style windfall
Fierce Biotech
Thursday, October 30, 2014 - 12:16pm
tags:
Chris Viehbacher, Sanofi
Acorda posts 3Q revenue of $106 million, result beats expectations
Yahoo/AP
Thursday, October 30, 2014 - 12:15pm
tags:
Acorda Therapeutics, earnings
Perrigo Said in Exclusive Talks to Acquire Omega Pharma
Bloomberg/Businessweek
Thursday, October 30, 2014 - 12:13pm
tags:
Perrigo, Omega Pharma, M&A
Smith & Nephew gains on Q3 results
Mass Device
Thursday, October 30, 2014 - 11:54am
tags:
earnings, Smith & Nephew, devices
J&J May Pay $250 Million to Settle 1,000 More Hip Claims
Bloomberg
Thursday, October 30, 2014 - 11:41am
tags:
JNJ, hip implants, Pinnacle Hip, devices
Dendreon And CMS Under SEC Scrutiny Over Insider Trading
Bidness Etc.
Thursday, October 30, 2014 - 10:09am
tags:
Dendreon, CMS, SEC, insider trading
AstraZeneca’s Diabetes Treatment Xigduo XR Wins FDA Approval
Bidness Etc.
Thursday, October 30, 2014 - 10:05am
tags:
AstraZeneca, diabetes, Xigduo XR, FDA
Pharma, Physicians And 'Open Payments': Moving From Data To Understanding
Forbes
Thursday, October 30, 2014 - 10:00am
tags:
CMS, physician payments, Physician Payment Sunshine Act
Bristol immunotherapy shows promise in lung cancer trial
Yahoo/AP
Thursday, October 30, 2014 - 9:58am
tags:
Bristol-Myers Squibb, non-small cell lung cancer, nivolumab
Teva optimistic U.S. top court to rule in favour of MS drug patent
Yahoo/Reuters
Thursday, October 30, 2014 - 9:29am
tags:
Teva Pharmaceutical, MS, multiple sclerosis, Copaxone
Teva Raises Forecast as Quarterly Profit Beats Estimates
Bloomberg
Thursday, October 30, 2014 - 9:25am
tags:
earnings, Teva Pharmaceutical
Novo Nordisk reassures on 2015 outlook after Sanofi jolt
Yahoo/Reuters
Thursday, October 30, 2014 - 9:23am
tags:
Novo Nordisk, Sanofi, Tresiba
Pacira posts 3rd-quarter loss of $3 million
Yahoo/AP
Thursday, October 30, 2014 - 9:20am
tags:
Pacira, earnings
Cubist Pharmaceuticals names chief executive
Pharmafile
Wednesday, October 29, 2014 - 3:51pm
tags:
Cubist Pharma
Pfizer meningitis vaccine wins U.S. approval
Yahoo/Reuters
Wednesday, October 29, 2014 - 3:47pm
tags:
Pfizer, vaccines, FDA, meningitis
Abbott buys into electrophysiology with $250m Topera acquisition
Mass Device
Wednesday, October 29, 2014 - 11:52am
tags:
Abbott Labs, electrophysiology, Topera, M&A, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.